SEVEN, TEN OR THIRTEEN? THE COST-UTILITY OF INFANT VACCINATION WITH A 7-, 10-OR 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN THE NETHERLANDS

被引：3
|
作者：
Vemer, P. [1 ]
de Greeff, S. C. D. [2 ]
Schouls, L. M. [2 ]
Al, M. J. [1 ]
de Melker, H. D. [2 ]
机构：
[1] Erasmus MC, Rotterdam, Netherlands
[2] Natl Inst Publ Hlth & Environm, RIVM, NL-3720 BA Bilthoven, Netherlands
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)74112-7
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A228 / A228
页数：1
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS OF SWITCHING FROM THE 10-VALENT TO THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN SWEDEN
    Wasserman, M.
    Dorange, A. C.
    Palmborg, A.
    McDade, C.
    Wilson, M.
    Horn, E.
    VALUE IN HEALTH, 2022, 25 (01) : S110 - S110
  • [22] Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: Comparing estimates for 7-valent, 10-valent, and 13-valent vaccines
    Tyo, Karen Richards
    Rosen, Melissa M.
    Zeng, Wu
    Yap, Mabel
    Pwee, Keng Ho
    Ang, Li Wei
    Shepard, Donald S.
    VACCINE, 2011, 29 (38) : 6686 - 6694
  • [23] Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia
    Rodrigo, Chamira
    Bewick, Thomas
    Sheppard, Carmen
    Greenwood, Sonia
    Mckeever, Tricia M.
    Trotter, Caroline L.
    Slack, Mary
    George, Robert
    Lim, Wei Shen
    EUROPEAN RESPIRATORY JOURNAL, 2015, 45 (06) : 1632 - 1641
  • [24] COST-EFFECTIVENESS OF SWITCHING STRATEGIES FROM A 7-VALENT TO A 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE
    Claes, C.
    Mittendorf, T.
    Kuchenbecker, U.
    Rose, M.
    Reinert, R. R.
    VALUE IN HEALTH, 2009, 12 (07) : A425 - A425
  • [25] Cost-effectiveness of a national immunization program with the 13-valent pneumococcal conjugate vaccine compared with the 10-valent pneumococcal conjugate vaccine in South Korea
    Kim, Hye-Young
    Park, Seong-Beom
    Kang, Eun-Sil
    Lee, Sang-Min
    Kim, Hyun-Jin
    Wasserman, Matt
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (03) : 909 - 918
  • [26] Pneumococcal Conjugate Vaccine-elicited Antibody Persistence and Immunogenicity and Safety of 13-Valent Pneumococcal Conjugate Vaccine in Children Previously Vaccinated with 4 Doses of Either 7-Valent or 13-Valent Pneumococcal Conjugate Vaccine
    Quinet, Beatrice
    Laudat, France
    Gurtman, Alejandra
    Patterson, Scott
    Sidhu, Mohinder
    Gruber, William C.
    Scott, Daniel A.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (10) : 1065 - 1076
  • [27] Pneumococcal vaccination strategies in adult population: perspectives with the pneumococcal 13-Valent polysaccharide conjugate vaccine
    Alicino, C.
    Barberis, I.
    Orsi, A.
    Durando, P.
    MINERVA MEDICA, 2014, 105 (01) : 89 - 97
  • [28] The cost-effectiveness of a 13-valent pneumococcal conjugate vaccination for infants in England
    van Hoek, Albert Jan
    Choi, Yoon Hong
    Trotter, Caroline
    Miller, Elizabeth
    Jit, Mark
    VACCINE, 2012, 30 (50) : 7205 - 7213
  • [29] THE COST-EFFECTIVENESS OF THE 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN CHINESE CITIES
    Furnback, W.
    Wang, B. C. M.
    Zhu, S.
    Dong, P.
    VALUE IN HEALTH, 2020, 23 : S170 - S170
  • [30] Cost-effectiveness of the 13-valent Pneumococcal Conjugate Vaccine in Children in Portugal
    Gouveia, Miguel
    Fiorentino, Francesca
    Jesus, Goncalo
    Costa, Joao
    Borges, Margarida
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2017, 36 (08) : 782 - 787
12345